The impact of immune-related adverse events on survival outcomes in a racially diverse population, with a focus on non-Hispanic Black patients
We demonstrated a similar incidence of irAEs in NHB patients with NSCLC as compared to other racial groups. Patients who developed irAEs experienced significantly improved survival outcomes. This association remained independent of race and ethnicity, underscoring the importance of providing unbiased treatment recommendations.
Authors
- Janice Weinberg (ORCID: https://orcid.org/0000-0002-3503-0061)
- Omar Al Omari (ORCID: https://orcid.org/0000-0002-7614-1729)
- Kei Suzuki (ORCID: https://orcid.org/0000-0002-2227-4737)
- Matthew H. Kulke (ORCID: https://orcid.org/0000-0001-8556-3977)
- Chinmay Jani (ORCID: https://orcid.org/0000-0001-9899-6333)
- Ümit Tapan (ORCID: https://orcid.org/0000-0002-3906-3004)
- Mohini Patel
- Amr Radwan (ORCID: https://orcid.org/0000-0001-6049-2068)
- Kimberley S. Mak (ORCID: https://orcid.org/0000-0002-7388-5124)
- Zoe Mackay
- Laura Burns (ORCID: https://orcid.org/0000-0003-3533-8266)
- Kiana Mahdaviani
- Liuping Li
- Peter C. Everett
- Amber Davidson
Institutions
- Boston University (US)
- Inova Health System (US)
- Boston Medical Center (US)
- Beth Israel Deaconess Medical Center (US)
- University of Miami (US)
- Sylvester Comprehensive Cancer Center (US)
- Temple University (US)
Publication Details
- Journal
- The Oncologist
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1093/oncolo/oyae279
- Citations
- 4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- National Institute on Minority Health and Health Disparities